ADA Website Accessibility Lawsuit: a biopharmaceutical company
Plaintiff's Firm: JOSEPH & NORINSBERG, LLC
Case Summary
Plaintiff Jaron Stephenson, a legally blind individual with Cone Rod Dystrophy and Type 1 Diabetes, initiated a federal lawsuit against a prominent biopharmaceutical company in the United States District Court for the Southern District of New York on September 22, 2025. Mr. Stephenson alleges that the defendant's primary digital gateway, which he relies upon for critical health information and patient support, is inaccessible to screen-reading software users, thereby violating Title III of the Americans with Disabilities Act and other relevant state and local laws.
Critically, the complaint details numerous accessibility barriers, including the absence of alternative text for product images, non-descriptive link text (such as "click here"), and unlabeled form fields crucial for login and other processes. Further technical deficiencies encompass keyboard traps, inaccessible modal dialogs, and an improper heading structure that impedes logical navigation. These systemic failures to comply with Web Content Accessibility Guidelines (WCAG) 2.1 Level AA prevent visually impaired users from accessing essential health resources, understanding treatment pipelines, and engaging with patient assistance programs.
This legal action, brought by JOSEPH & NORINSBERG, LLC, underscores the pervasive digital exclusion faced by disabled individuals when online platforms fail to integrate fundamental accessibility standards like semantic markup and ARIA roles. Such a lawsuit highlights significant legal exposure for entities across all sectors that maintain public-facing websites without adhering to established digital inclusion guidelines, potentially leading to injunctive relief, compensatory damages, and class action certification for millions of underserved users.
Unlock Full Intelligence Report
Obtain the technical WCAG violation analysis, target metadata, and legal stakes for Case #NY-71421902.
Case Q&A
What were the principal digital barriers encountered on the biopharmaceutical company's website?
The plaintiff reported encountering numerous accessibility barriers, including missing alternative text for images, non-descriptive link text, unlabeled form fields, keyboard traps, inaccessible modal dialogs, and improper heading structures, all of which rendered the website incompatible with screen-reading software.
Who brought this action and which law firm represents them?
The lawsuit was initiated by Jaron Stephenson, a visually impaired individual. He is represented by the law firm JOSEPH & NORINSBERG, LLC.
What broad implications does this case have for other businesses with online platforms?
This litigation suggests that businesses operating digital platforms must proactively implement and maintain WCAG 2.1 Level AA standards to avoid claims of discrimination under the Americans with Disabilities Act, and could face demands for significant remediation, damages, and injunctive orders if their websites are not equally accessible.